ad info

CNNin
 MAIN PAGE
 WORLD
 ASIANOW
 U.S.
 LOCAL
 POLITICS
 WEATHER
 BUSINESS
 SPORTS
 TECHNOLOGY
 NATURE
 ENTERTAINMENT
 BOOKS
 TRAVEL
 FOOD
 HEALTH
 AIDS
 Alternative
 Cancer
 Diet & Fitness
 Heart
 Men
 Seniors
 Women
 STYLE
 IN-DEPTH

 Headline News brief
 daily almanac
 CNN networks
 CNN programs
 on-air transcripts
 news quiz

  CNN WEB SITES:
CNN Websites
 TIME INC. SITES:
 MORE SERVICES:
 video on demand
 video archive
 audio on demand
 news email services
 free email accounts
 desktop headlines
 pointcast
 pagenet

 DISCUSSION:
 message boards
 chat
 feedback

 SITE GUIDES:
 help
 contents
 search

 FASTER ACCESS:
 europe
 japan

 WEB SERVICES:
Health

Breast cancer vaccine trials show promise

graphic January 14, 1999
Web posted at: 10:00 a.m. EDT (1400 GMT)

ATLANTA (CNN) -- As routinely as some people might drop in for an allergy shot, Jennifer Clarke visits Atlanta's Northside Hospital once a month for a cancer vaccine.

Clarke doesn't mind getting stuck by a needle. Just six months ago, she was undergoing debilitating chemotherapy treatment for breast cancer that had spread to her liver.

Then she was selected as one of a handful of women -- whose cancer could not be easily controlled by conventional means -- to receive an experimental cancer vaccine.

"The strategy here is to immunize patients with this tumor vaccine against breast cancer, to actually get the person's own immune system to attack their disease as opposed to just giving them medication," explained Dr. Kent Holland.

The vaccine is designed to prime the immune system, so the body might recognize and destroy any new cancer cells before they take hold.

"To date, about 15 women nationwide have been entered in this trial, and what we do know is that a significant number of the patients are responding well to the vaccine," Holland said.

However, the long-term effectiveness of the vaccine is still not known.

X-ray
X-ray of a cancerous liver  

In Clarke's case, her liver has recovered significantly and now appears almost normal. Doctors say the chemotherapy and other conventional treatments she underwent likely cleared up the tumors. The test of the vaccine will be whether it can prevent them from growing back.

Clarke will continue to receive the monthly shots for the next two years as a participant in the vaccine trials. The worst side effect so far, she said, is a sore arm.

"Anything that's going to benefit someone else in the future, I'm really glad to be part of that," Clarke said. "And (benefit) myself in the meantime, hopefully."

Medical Correspondent Dan Rutz contributed to this report.

Related stories:
Latest Headlines

Today on CNN

Related sites:

Note: Pages will open in a new browser window

External sites are not
endorsed by CNN Interactive.

SEARCH CNN.com
Enter keyword(s)   go    help

  
 

Back to the top
© 2000 Cable News Network. All Rights Reserved.
Terms under which this service is provided to you.
Read our privacy guidelines.